4 | SEC Filings Hub

Filing metadata

Accession number: 0001859061-23-000004
Form type: Form 4
Filer: A2A Pharmaceuticals, Inc.
CIK: CIK 1859061
Filed: Apr 26, 2023
Reporting period: Apr 20, 2023
Description: Insider transaction

Documents

0001859061-23-000004-index.htm

Complete submission

0001859061-23-000004.txt

directory listing

Filed by

A2A Pharmaceuticals, Inc.